# VISSIT Intracranial Stent Study for Ischemic Therapy

> **NCT00816166** · PHASE2,PHASE3 · TERMINATED · sponsor: **Codman & Shurtleff** · enrollment: 125 (actual)

## Conditions studied

- Ischemic Stroke
- Transient Ischemic Attack

## Interventions

- **DEVICE:** Pharos Vitesse Neurovascular Stent System (Stent implantation) + Medical therapy (Aspirin and Clopidogrel)
- **DRUG:** Aspirin and Clopidogrel (Medical therapy)

## Key facts

- **NCT ID:** NCT00816166
- **Lead sponsor:** Codman & Shurtleff
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-10
- **Primary completion:** 2013-04
- **Final completion:** 2014-06
- **Target enrollment:** 125 (ACTUAL)
- **Last updated:** 2015-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00816166

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00816166, "VISSIT Intracranial Stent Study for Ischemic Therapy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00816166. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*